Bright Minds Biosciences Inc (DRUG)
R&D Expense Growth
839.36%
Fiscal year · Period ending:
DRUG R&D Expense Growth
Latest reported839.36%period ending
Latest reported839.36%period ending
DRUG FY R&D Growth (YoY) (0.00% → 839.36%)
Latest values, visible window
High-resolution chart · PNG
DRUG r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 839.3572% | |
| -76.3995% | |
| -58.9527% | |
| 92.9199% | |
| 1,679.33% | |
| 181.5682% | |
| 0% |